Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

7.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.2K
Inflammation01:38

Inflammation

55.1K
Overview
55.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

214
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
214
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

5.3K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
T Cell Types and Functions01:24

T Cell Types and Functions

1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Achievement of Low-Density Lipoprotein Cholesterol Management Goals: Implications on High-Risk Cardiovascular Disease Patients Within the Japan Atherosclerosis Society 2022 Guideline Recommendations.

Circulation reports·2026
Same author

Secondary Giant Cardiac Lymphoma Treated by Stepwise Chemotherapy With Multimodal Imaging.

JACC. Case reports·2026
Same author

The rs10781468 Genetic Polymorphism of the Gαq (GNAQ) Gene Is Associated With Responsiveness to Opioid Analgesics in Patients With Postoperative and Cancer Pain: An Exploratory Study.

Neuropsychopharmacology reports·2026
Same author

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same author

Lysophosphatidic Acid 18:0 sn-1 in Cerebrospinal Fluid as a Potential Biomarker of Depressive Symptoms in Patients with Neuropathic Pain.

Brain sciences·2026
Same author

Protective effects of PRELP protein in a mouse model of pulmonary fibrosis.

Respiratory research·2026

Related Experiment Video

Updated: Sep 11, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K

C-reactive protein modulates lipid mediators in a pro-inflammatory direction.

Makoto Kurano1,2,3, Kazuhisa Tsukamoto4,5, Hideaki Isago6

  • 1Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. kurano-tky@umin.ac.jp.

Journal of Inflammation (London, England)
|August 13, 2025
PubMed
Summary

C-reactive protein (CRP) influences atherosclerosis by altering bioactive lipid mediators. This study found CRP increases pro-inflammatory lipids and decreases anti-inflammatory ones, potentially driving disease progression.

Keywords:
C-reactive proteinEicosanoidsInflammationLysophospholipidsW3-fatty acid mediators

More Related Videos

On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.0K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

Related Experiment Videos

Last Updated: Sep 11, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.4K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.0K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.7K

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiovascular Research

Background:

  • C-reactive protein (CRP) is a known risk factor for atherosclerosis.
  • While inflammation may confound this association, CRP itself is suspected of having pro-atherosclerotic and pro-inflammatory roles.

Purpose of the Study:

  • To investigate the mechanisms by which CRP modulates bioactive lipid mediators.
  • To understand CRP's role in lipid metabolism and inflammation relevant to atherosclerosis.

Main Methods:

  • Overexpression of human CRP in mice and HepG2 cells.
  • Analysis of cytokine levels (IL-6, TNF-a) in plasma and cell culture.
  • Comprehensive lipidomics analysis of plasma samples.
  • Investigation of CRP's binding interactions with specific lipid mediators.

Main Results:

  • CRP overexpression elevated plasma IL-6 and TNF-a levels in mice.
  • CRP increased plasma levels of lysophospholipids and sphingosine 1-phosphate.
  • CRP promoted pro-inflammatory lipid mediators (e.g., PGE2, LTA4 metabolites) while reducing anti-inflammatory ones (EPA, DHA derivatives).
  • CRP was found to bind directly to mediators like sphingosine 1-phosphate, PGE2, and PGF2a.

Conclusions:

  • CRP modulates lysophospholipids and eicosanoids.
  • These modulations appear to be in pro-atherosclerotic and pro-inflammatory directions.
  • CRP may directly influence lipid mediator pathways contributing to atherosclerosis.